Kimberly-Clark is betting $40 billion that, despite the HHS Secretary’s unwarranted accusations about Tylenol, purchasing Kenvue will create synergies that will turn the combined company into a ...

Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue in a deal valued at $48.7 billion. CNBC's David Faber breaks down the details. Donald Trump stimulus check update: White House ...

DALLAS (AP) — Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal, creating a massive consumer health goods company.

Federal Reserve Chair Jerome Powell agrees that there’s probably something to the claims of a K-shaped economy. But at last week’s press conference, he failed to note how the Fed has helped to create ...